PCVX vs REGN: Which Stock is Better?
Side-by-side comparison of Vaxcyte Inc and Regeneron Pharmaceuticals Inc in 2026
PCVX
Vaxcyte Inc
$62.35
REGN
Regeneron Pharmaceuticals Inc
$750.57
Key Metrics Comparison
| Metric | PCVX | REGN | Winner |
|---|---|---|---|
| Market Cap | $9.03B | $78.87B | REGN |
| P/E Ratio | N/A | 17.98 | REGN |
| EPS (TTM) | $N/A | $41.48 | REGN |
| Revenue Growth | 0.0% | 0.0% | REGN |
| Gross Margin | 0.0% | 44.6% | REGN |
Analyze PCVX
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PCVX or REGN a better investment?
Comparing PCVX and REGN: Vaxcyte Inc has a market cap of $9.03B while Regeneron Pharmaceuticals Inc has $78.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PCVX and REGN?
PCVX (Vaxcyte Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PCVX or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PCVX or REGN?
REGN has higher revenue growth at 0.0% vs 0.0% for PCVX.
Which company is more profitable: PCVX or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for PCVX.
Which is the larger company: PCVX or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.87B compared to $9.03B for PCVX.
Should I buy PCVX or REGN in 2026?
Both PCVX and REGN have investment merit. PCVX trades at $62.35 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PCVX and REGN stock?
Key differences: Market Cap ($9.03B vs $78.87B), P/E Ratio (N/A vs 18.0x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).